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Alport syndrome [1] is a genetic renal disease characterized by
hematuria and varying degrees of proteinuria, sensorineural hear-
ing loss, and less frequently ocular lesions (lenticonus, macular
lesions). Diverse mutations of the COL4A5 gene encoding the
alpha 5 chain of basement membrane type IV collagen have been
characterized in patients with X-linked Alport syndrome. Almost
every affected family harbors a unique sequence change. There-
fore, the mutation search in patients with Alport syndrome
depends to a great extent on sensitivity and speed of the applied
methods. In addition, future clinical diagnostic applications intro-
duce economical aspects as to which method is chosen for
mutation searches.
Screening for mutations in Alport syndrome usually involves
PCR amplification of single exons and subsequent analysis by
single strand conformation polymorphism electrophoresis (SSCP)
or, with even higher reported sensitivity, by denaturing gradient
gel electrophoresis (DGGE) [2—4]. These techniques are based
upon the detection of altered gel mobility of mutated DNA as
compared to wild-type DNA. DGGE has been reported to be
suitable for DNA fragments of 100 to 400 bp in length. One
drawback is that mutations only in the domain with the lowest
melting point are usually detectable. To circumvent this problem,
long stretches (40 bp) of GC are added to one of the primers and
then integrated into the PCR product to be analyzed. The
so-called GC-clamps have very high melting temperatures and
confine the adjacent DNA sequence to a single, flat melting
domain that is amenable for DGGE detection of single base
changes. GC-clamps have been reported to greatly increase the
range of detectable mutations [2]. Besides the expense of synthe-
sizing GC-primers, technical problems may occur with optimiza-
tion of PCR conditions and yield because of the asymmetry of
primer sets. Recently, psoralen phosphoramidites have become
commercially available for use with oligonucleotide synthesizers.
DNA amplified with a primer set containing one psoralen coupled
primer can be covalently crossliriked by exposure to UV light.
There is some evidence in the literature that psoralen photo
crosslinked DNA behaves like GC-clamped DNA [5]. In this
paper, we evaluated psoralen photo crosslinking as a less costly
alternative to GC-clamping when applied to mutation screening
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of COL4A5 exons 47 to 51 in Alport syndrome. By using this
technique, three new mutations could be identified.
Methods
Patients
DNA of patients from 32 unrelated families who had not been
included in previous investigations [6, 7] were examined for
mutations in the NCI coding region of COL4A5 (exons 47 to 51).
The diagnosis of Alport syndrome had been made clinically
according to criteria published before [8]. Clinical characteristics
of the three patients with newly identified mutations were as
follows: A4992G (protein level: Y1597C), typical ultrastructural
changes of the glomerular basement membrane, persistent micro-
hematuria, creatinine 1.3 mg/dl (age 30), proteinuria 6.5 g/day,
sensorineural hearing loss noticeable only by audiometry, no
ocular lesions; C5222T (protein level: R1674STOP), essentially
the same symptoms (age 20); and G5244A (protein level:
C1681Y), EM not done, microhematuria, > 3 g/day proteinuria,
end-stage renal disease at 31 years, clinically overt sensorineural
hearing loss, lenticonus anterior. The patients whose DNA con-
tained the two known exon 49 mutations that were used as
controls, had the following symptoms: control 1 (C1564S [9, 10]),
end-stage renal disease at 33 years (intrakindred mean), clinically
overt hearing loss, no ocular abnormalities; and control 2 (M1601l
and splice site inactivation [11]), end-stage renal disease at 15
years, no hearing loss, no ocular abnormalities.
PCR
Genomic DNA was extracted as described previously [12]. One
hundred nanograms of genomic DNA was used for each PCR
amplification of exons 47 to 51, respectively, under standard buffer
conditions. Thirty-five cycles of 95°C160 minutes, X°C/60 minutes,
72°C130 minutes were commonly performed. As summarized in
Table 1, for each exon one unmodified primer was used in
combination with one of three different opposite primers (unmod-
ified, GC-clamped, or psoralen-coupled). Primers labeled "Ps"
contained at their 5' ends a psoralen derivative [2-(4'-(hydroxy-
methyl)-4,5',8-trimethylpsoralen)-ethyl] (Glen Research, Sterling,
VA, USA). AA dinucleotide spacers were introduced because
psoralen intercalates most efficiently with thymidine residues on
the opposite strand [13]. Our own initial experiments with two Ps
primers indicated that the efficiency of photo crosslinking was
indeed greatly reduced (< 30%) when the AA spacer was omitted
from the primer sequence (not shown). In agreement with the
literature [5] we concluded that it was generally advisable to
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Table 1. Primer sequences, PCR conditions
PCR
primer Sequence
Annealing
temp. X°C
47A GACTGGATCAGAGCTTACT 58
47A-Ps Ps -AAGAGTGGATCAGAGCTTACT 58
47A-GC (GC) -GAGTGGATCAGAGCTTACT 58
47B GAACCCAACAGGATTTCTGA
48A CACGCAGTCCTTTACTGTTT
48B-Ps Ps-AATCTGACTAGCTAACTAACTGG 58
48B-GC (GC) 20-TCTGACTAGCTAACTAACTGG 58
48B TCTGACTAGCTAACTAACTGG 58
49A GTAGATTATGTTCCTTCTCC
49B-Ps Ps-AATGGACAGTCAGCTATGATG 58
49B-GC (GC) 70-TCGACAGTCAGCTATGATG 58
49B TGGACAGTCAGCTATGATG 58
50A TATGGCAOATGGGTATTGCG
50B-Ps Ps -AATCTGAAGGAAGCTTTGGACCT 58
50B-GC (GC) 20-TCTGAAGGAAGCTTTGGACCT 58
50B TCTCAAGGAAGCTTTGGACCT 58
51A TCTGGATCTGATTGTCTTA 54
51A-Ps Ps -AATGTGGATCTGATTGTCTTA 54
51A-GC (Gc) 20-TGTGGATCTGATTGTCTTA 54
51B AACACAAAAGGAATTCTTCAA
include AA spacers with psoralen primers. Photo crosslinking was
achieved by long wave UV-irradiation after combining and rean-
nealing PCR products from two different patients (see below).
Samples in 0.5 ml PCR tubes were placed on aluminum foil 1.5 cm
underneath a portable 4W UV source and irradiated for various
time periods (0 to 30 mm) at 365 nm in order to determine
optimal crosslinking conditions. After UV irradation, PCR prod-
ucts were ready for analysis by DGGE.
Denaturing gradient gel electrophoresis
Peipendicular DGGE. Melting profiles of COL4AS exon 47 to
51 PCR products were experimentally tested by perpendicular
denaturing gradient gel electrophoresis (DGGE). DNA from
three identical 100 d reactions was combined and applied to the
surface of a 6.8% polyacrylamide gel containing a 0 to 45% linear
gradient of denaturants (100% being equivalent to 40% form-
amide and 7 M urea) perpendicular to the direction of electro-
phoresis. The gel was immersed into a buffer tank containing 1 X
TAE (40 mist Tris, 1 mist EDTA, pH 8.0). Buffer and gel
temperatures were kept constant at 60°C during electrophoresis.
Gels were run at 200 V for 2.5 hours. After disassembling the
electrophoresis chamber (Hoefer SE 600), DNA was visualized by
silver staining (BioRad).
Parallel DGGE. Parallel DGGE with varying gradients (Table
2) of denaturants in a 6.8% polyactylamide gel along the direction
of electrophoresis was then performed to screen Alport patients
for mutations in COL4A5 exons 47 to 51. Two positive controls
with known mutations at the 5<< end of exon 49 (control 1:
G4893C [91) and at the 3<< end of exon 49 (control 2: G5005C
[ill) were included. The DNA samples were kindly provided by
Dr. J. Zhou (Boston, MA, USA), and Dr. S. Nomura (Kurashiki,
Japan). DNA from normal individuals served as control. Prior to
electrophoresis and UV irradiation, 70 ng of PCR product from
two different patients were combined to form heteroduplexes. The
samples were denatured at 95°C for 10 minutes, reannealed at
Table 2. DGGE conditions
PCR
primer
Melting
Midpoint °C
DGGE
gradient %
Running
time Vii
UV-Irradiation
mm
47A-Ps/47B 70 5—35 770 15
48AJ48B-Ps 71 10—40 770 15
49A/49B-Ps 72 15—45 770 15
50A/50B-Ps 71 10—40 770 15
51A-Ps/51B 71 10—40 770 15
55°C for one hour, and then applied to a parallel DGG. After
running the gel for 7.7 hours at 100 V at 60°C, DNA was detected
by silver staining (BioRad). PCR products showing abnormal
migration patterns were directly sequenced using PCR in combi-
nation with dideoxy chain termination (Gibco BRL) as described
previously [7].
Results
Peipendicular DGGE and optimization of psoralen photo
crosslinking
Photo crosslinking creates a covalent bond between two DNA
strands and assumedly confines their melting profile to a single
flat melting domain similar to that of GC-clamped DNA [5]. In
order to verify this experimentally, the melting behavior of
GC-clamped and psoralen photo crosslinked PCR products for
exons 47 to 51 were assessed by perpendicular DGGE. The results
showed that for each of the five exons, psoralen photo crosslinking
induced a modification of the melting profile similar to GC-
clamps. As an example, silver stains of the two gels containing
PCR products 49A/B-GC and 49A/B-Ps, respectively, are shown
in Figure 1. The denaturant gradient range corresponded to an
approximate temperature gradient of 60 to 75°C. In the GC-
clamped DNA fragment, two melting domains were present as
indicated by inflections in the curve (Fig. 1, top). Melting mid-
points were at °°18% (that is, 66°C) for the low melting domain,
and at °°35% (72°C) for the high melting domain. The high
melting domain corresponds to the exon sequence and is there-
fore most relevant for mutation analyses. The melting curve for
psoralen photo crosslinked DNA was essentially identical, show-
ing the same domains and melting midpoints (Fig. 1, bottom). On
this gel, an additional curve (*) could be distinguished with a
single melting domain and a melting midpoint at °°18% (66°C),
representing most likely DNA that had not been photo
crosslinked and therefore behaved like "native" PCR product (gel
not shown). The origin of a very faint curve with a melting
midpoint at °°30% remained unclear. It might be possible that this
curve represented DNA with intercalated but not crosslinked
psoralen that was only partially stabilized.
Perpendicular DGGE allowed us to determine melting mid-
points for each exon PCR product (Table 2). On the basis of these
results, denaturant gradient ranges where determined for the
parallel gels that were later used to screen patients' DNA. The
gradients were chosen to cover denaturant concentration ranges
of 30% around the high melting midpoint of each PCR product
(Table 2). Under these conditions, constant running times of 770
Vh were sufficient to electrophorese the DNA fragments through
3/4 of the entire gel, taking them well into temperature ranges
equal to their exon melting midpoints.
The efficiency of the photo crosslinking procedure varied
0% 10% 20% 30% 40%
GC-clamp
Psoralen
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Fig. 1. Perpendicular DGGE. Comparison of
perpendicular DGGE analysis of GC-clamped
exon 49 PCR product (top), and of psoralen
photo crosslinked exon 49 PCR product
(bottom). Approximately 1.5 g PCR products
were separated in a 6.8% polyacrylamide gel
containing a 0 to 45% gradient of denaturants
perpendicular to direction of electrophoresis.
Arrows indicate the melting domains. The
presence of non-crosslinked material leads to a
separate curve on the psoralen gel (*), which is
identical to that of unmodified PCR product.
Fig. 2. Optimization of irradiation time. Exon 49
PCR product from mutated control 2 DNA, as
well as normal control DNA were divided into
10 aliquots, exposed to 365 nm UV light for the
indicated times, and separated on a 15 to 45%
parallel DGG. Highest band intensity for
heteroduplex (arrows) and homoduplex (*)
DNA, and a low ratio of uncrosslinked material
(at the bottom of the gel) was achieved after 15
minutes of UV exposure.
slightly between the different exon PCR products. In the case of
exon 49 it was estimated to be only 50% (Fig. 1, bottom). In an
attempt to optimize the procedure, PCR samples of each exon
were exposed to UV light (365 nm) for various time periods.
Samples were then analyzed on gels containing a parallel gradient
of denaturants. Figure 2 shows an example for exon 49, amplified
from mutated control DNA 2, and normal DNA. With increased
irradiation time, "native," that is, unlinked, 49A/B-Ps product
disappeared and crosslinked product increasingly appeared.
Longer exposure (20 or 30 mm) to 365 nm UV light lead to a
somewhat decreased signal strength. The optimal exposure time
for 49A/B-Ps product was determined to be 15 minutes when
heteroduplex bands indicating the presence of a mutation were
seen with the highest intensity. UV exposure of 15 minutes also
appeared to be working well for the other exons tested (summa-
rized in Table 2).
Mutation detection in A/port patients
Psoralen photo crosslinking/DGGE was applied to screen DNA
from 32 patients with Alport syndrome for mutations in COL4A5
exons 47-51. PCR, photo crosslinking and DGGE conditions were
as listed in Tables 1 and 2. Denaturing gradient gels for exons 49
and 51 are shown in Figure 3 A and B, respectively. Variant
patterns in lanes 8 (Fig. 3A), and 2/3 and 5/6 (Fig. 3B) clearly
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slightly better [5], indicating that the findings presented here for
exon 49 might not be generalized.
Discussion
Fig. 3. Screening fbr new mutations. A. Parallel DGGE analysis of psor-
alen photo crosslinked exon 49 PCR products from one control (lane 1)
and 13 patients' DNA (lanes 2 to 14). The presence of displaced
homoduplex (*) and heteroduplex bands (arrows) in lane 8 indicates the
presence of a mutation (A4992G). B. Analysis of photo crosslinked exon
51 PCR products from one control (lane 1) and 8 patients (lanes 2 to 14).
All lanes, except 4 and 7 are in duplicates. Displaced homoduplex (*) and
heteroduplex bands (arrows) in lanes 2/3, and heteroduplex bands (ar-
rows) in lanes 5/6 indicate mutations (G5244A, C5222T).
indicated the presence of sequence changes. Sequencing revealed
the following mutations: A4992G, G5244A, C5222T. The A to G
and G to A transitions caused both variant heteroduplex (arrows)
and homoduplex (*) bands, while the C to T transition showed
only heteroduplex (arrows) bands. The other patients or controls
did not show any abnormalities.
Comparison of GC-clamping and psoralen photo crosslinking
To further demonstrate equal capability of GC-clamping and
psoralen photo crosslinking/DGGE to resolve mutations, three
different mutations in exon 49 were analyzed: one newly identified
mutation (A4992G), and two well-characterized base substitu-
tions at the 5' and 3' ends of the exon, respectively (G4893C,
G5005C; [9, 11]). The exon 49 regions were PCR-amplified with
primer pairs 49A/B ("native"), 49A/B-GC (GC-clamped), and
49A/B-Ps (photo crosslinked), and analyzed by parallel DGGE
(Fig. 4). With primer pair 49A!B, only two mutations were
resolved, but the displaced heteroduplex bands were not well
focused and not easy to see (Fig. 4, lanes I and 2). With control
mutation 2 (G5005C), no heteroduplex bands were visible (Fig. 4,
lane 3). GC-clamping clearly improved detectability of all three
mutations. The heteroduplex bands were focused and somewhat
more displaced, resulting in a pattern more clearly distinguished
from the normal (Fig. 4, lanes 5 to 8). In addition, GC-clamping
allowed resolution of two mutations (A49920 and G4893C) with
displaced homoduplex bands (*). Psoralen photo erosslinking
improved the detectability of all three mutations in the same way.
In the particular case of this exon, it also lead to heteroduplex
hands that appeared more intense, thereby facilitating the sample
analysis further (Fig. 4, lanes 9 to 12). In the literature, however,
DGGE patterns with GC-clamping were often found to look
Sensitive and rapid screening of the COL4A5 gene for muta-
tions in patients with Alport syndrome is hampered by the
heterogeneity of sequence changes and their even distribution
among the 51 exons of the gene. In this study we demonstrate a
first example for the successful application of psoralen photo
crosslinking/DGGE to screen Alport patients.
DGGE analysis was performed on PCR fragments containing
exon- and adjacent intron sequence. This normally requires
modification of the melting profile by the addition of GC-clamps
to one of the primers in order to increase resolution of sequence
changes in high melting domains, usually the exons. With psoralen
phosphoramidites that can he coupled to the 5' ends of oligo
nucleotide primers, a less costly substitute for GC-clamps (usually
an extra 40 bases) has become available. Psoralen has been
reported to efficiently crosslink the two strands of PCR fragments
upon exposure to UV light (365 nm), thereby introducing a high
melting domain into the molecule at stake [51.
Our experiments with perpendicular DGGE confirmed that
GC-clamping and psoralen photo crosslinking of COL4A5 exons
47-51 PCR products created identical melting profiles. This
indicated that both approaches might be used interchangeably,
with cost advantage for psoralen. Perpendicular DGGE also
allowed to determine melting midpoints for the exons to be
screened. Based upon these results, denaturant gradient ranges
for parallel screening gels were designed such that electrophoresis
for 770 volt hours (Vh) would take the DNA fragments well into
temperature ranges equal to the exon melting temperatures. Time
series of UV irradiation showed for all five exons that 15 minutes
exposure time were optimal. PCR, photo crosslinking and DGGE
conditions for all five exons could thus he optimized with minor
procedural variations.
Psoralen photo crosslinking/parallel DGGE was successfully
applied to screen Alport patients for mutations in COL4A5 exons
47 to 51. Assuming an even distribution of mutations in the 51
COL4A5 exons, the screening of five exons generates a 0.1
likelihood of finding one. In 32 non-related patients, we identified
three new mutations, one in exon 49, and two in exon 51. Two
mutations created amino acid substitutions, one created a trans-
lational STOP codon causing the C-terminal 12 residues of the
alpha 5 type IV collagen chain to be absent. Clinical features of
the affected individuals point to a rather slow disease progression
with end-stage renal disease occurring at > 30 years of age. Other
mutations associated with adult onset of end-stage renal failure
also reside in the 3' end of COL4A5 [14—171. These include two
misserise-mutations, one short insertion, and one duplication!
inversion. One patient out of these four did not have any hearing
loss, and three did not have ocular changes. Altogether, it remains
uncertain whether the specific clinical features of patients with
newly discovered mutations can be linked to the respective types
and locations of the mutations. Obviously, more mutations have
to be characterized prior to attempt genotype-phenotype correla-
tions.
In addition to demonstrating successful mutation screening
with psoralen photo crosslinking!DGGE, we compared the
DGGE analysis of GC-clamped and psoralen photo crosslinked
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Fig. 4. Comparison of DGGE resolution of three
different COL4A5 exon 49 mutations using
unmodified PCR primers, GC-clamped, and
psoralen photo cross/inked primers. Patient DNA
(A4992G; lanes 1, 5, 9), control 1 DNA
(G4893C; lanes 2, 6, 10), control 2 DNA
(G5005C; lanes 3, 7, 11), and normal control
DNA (lanes 4, 8, 12) was amplified with normal
and modified exon 49 primers. Subsequently,
PCR products were separated on a 15 to 45%
parallel DGG. With unmodified primers, only
two of the mutations showed heteroduplex
bands (arrows). In contrast, all three mutations
showed displaced homoduplex bands (*) and/or
heteroduplex bands (arrows) with either primer
modification.
PCR products. Three different mutations in exon 49 were ana-
lyzed as an example. In line with the literature on DGGE [2, 3],
this experiment demonstrated a much improved resolution of all
three mutations with modified PCR products as compared with
unmodified PCR products. Both modification techniques seemed
to be effective in producing easily recognizable patterns in the
presence of mutations. With regard to economical reasons, how-
ever, psoralen photo crosslinking was advantageous.
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